Ignite Creation Date:
2024-05-06 @ 7:26 PM
Last Modification Date:
2024-10-26 @ 3:07 PM
Study NCT ID:
NCT06017713
Status:
RECRUITING
Last Update Posted:
2024-02-14
First Post:
2023-08-24
Brief Title:
tDCS Associated With Symptom Provocation in the Management of Patients With Resistant Obsessive Compulsive Disorder
Sponsor:
Centre Hospitalier Henri Laborit
Organization:
Centre Hospitalier Henri Laborit
Study Overview
Official Title:
Direct Transcranial Stimulation With Direct Current Associated With Symptom Provocation in the Management of Patients With Resistant Obsessive Compulsive
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PPSTDCS-TOC
Brief Summary:
This is a single-center study about patients with severe resistant OCD
Main assumption is that performing 10 tDCS sessions with the anode positioned at the level of the right orbitofrontal cortex and the cathode at the level of the supplementary motor area associated with the provocation of symptoms before each session is effective in the reduction in obsessive-compulsive symptoms
After the inclusion visit the treatment period is provided from D1 to D12 one session per day from Monday to Friday for two consecutive weeks ie a total of ten sessions Each tDCS session lasts 30 minutes at an intensity of 2 mA and is preceded by symptom provocation using a standardized procedure performed by trained personnel
The patients are then assessed on D42 and D102 ie 1 month and 3 months after the end of the tDCS sessions
Main assumption is that performing 10 tDCS sessions with the anode positioned at the level of the right orbitofrontal cortex and the cathode at the level of the supplementary motor area associated with the provocation of symptoms before each session is effective in the reduction in obsessive-compulsive symptoms
After the inclusion visit the treatment period is provided from D1 to D12 one session per day from Monday to Friday for two consecutive weeks ie a total of ten sessions Each tDCS session lasts 30 minutes at an intensity of 2 mA and is preceded by symptom provocation using a standardized procedure performed by trained personnel
The patients are then assessed on D42 and D102 ie 1 month and 3 months after the end of the tDCS sessions
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None